期刊
FRONTIERS IN ONCOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.1047907
关键词
mesenchymal stem cells; cancer immunotherapy; extracellular vesicles; innate immune cells; adaptive immune cells
类别
资金
- Natural Science Foundation of Chongqing [cstc2020jcyj-msxmX0064]
This review discusses the use of mesenchymal stem cells (MSCs) in cancer immunotherapy and their immunomodulatory mechanisms in cancers, which are the primary factors influencing the different outcomes of MSCs therapies for tumors.
Mesenchymal stem cells (MSCs) have been used to treat various diseases including Alzheimer's disease and cancer. In particular, the immunomodulatory function of MSCs plays a major role in cancer therapy using stem cells. However, MSCs exert promotive and inhibitory effects on cancer. The immunomodulatory effects of MSCs in the tumor microenvironment (TME) are ambiguous, which is the primary reason for the different outcomes of MSCs therapies for tumors. This review discusses the use of MSCs in cancer immunotherapy and their immunomodulatory mechanisms in cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据